Form 4: Mind Medicine (MindMed) Inc.: Chief Commercial Officer Matthew T. Wiley Reports Stock Option Grant

Matthew T. Wiley, Chief Commercial Officer of Mind Medicine (MindMed) Inc., reports the acquisition of stock options for 350,000 common shares.

Summary

• On March 17, 2025, Matthew T. Wiley, Chief Commercial Officer of Mind Medicine (MindMed) Inc., was granted stock options to purchase 350,000 common shares.
• The exercise price of the options is $6.35 per share.
• The options vest over a four-year period, with 25% vesting on the first anniversary of the grant date and the remaining 75% vesting in 36 equal monthly installments thereafter, contingent upon continuous service to the Issuer.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects a standard executive compensation practice, indicating confidence in the company's future, but it's not overwhelmingly positive as it's a routine event.

Positives

• The grant of stock options aligns the interests of the Chief Commercial Officer with those of the shareholders, incentivizing him to contribute to the company's long-term success.
• The vesting schedule encourages continued service and commitment to the company over a four-year period.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the stock options.

Industry Context

Stock option grants are a common practice in the pharmaceutical and biotechnology industries to attract and retain key executives and align their interests with those of shareholders. This grant is consistent with industry norms for executive compensation.

Comparison to Industry Standards

• Stock option grants are a standard component of executive compensation packages in the biotech industry.
• Companies like Compass Pathways and Atai Life Sciences also utilize stock options to incentivize their executives.
• The vesting schedule and exercise price are typical for similar grants in comparable companies.

Stakeholder Impact

• Shareholders may view the stock option grant as a positive sign, aligning management's interests with the company's long-term success.
• Employees may see this as a sign of stability and commitment to the company's future.

Key Dates